BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11815979)

  • 21. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus.
    Hermann B; Li Y; Ray MB; Wo JM; Martin RC
    Arch Surg; 2005 Dec; 140(12):1204-9; discussion 1209. PubMed ID: 16365243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX2 as a novel marker to predict neoplastic progression in Barrett's esophagus.
    van Olphen S; Biermann K; Spaander MC; Kastelein F; Steyerberg EW; Stoop HA; Bruno MJ; Looijenga LH
    Am J Gastroenterol; 2015 Oct; 110(10):1420-8. PubMed ID: 26323187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.
    Jiang K; Neill K; Cowden D; Klapman J; Eschrich S; Pimiento J; Malafa MP; Coppola D
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):552-556. PubMed ID: 27941559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
    Herszenyi L; Hritz I; Pregun I; Sipos F; Juhasz M; Molnar B; Tulassay Z
    World J Gastroenterol; 2007 Feb; 13(5):676-82. PubMed ID: 17278189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acidic fibroblast growth factor is progressively increased in the development of oesophageal glandular dysplasia and adenocarcinoma.
    Soslow RA; Nabeya Y; Ying L; Blundell M; Altorki NK
    Histopathology; 1999 Jul; 35(1):31-7. PubMed ID: 10383711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Walch A; Specht K; Bink K; Zitzelsberger H; Braselmann H; Bauer M; Aubele M; Stein H; Siewert JR; Höfler H; Werner M
    Lab Invest; 2001 Jun; 81(6):791-801. PubMed ID: 11406641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.
    Villanacci V; Bellone G; Battaglia E; Rossi E; Carbone A; Prati A; Verna C; Niola P; Morelli A; Grassini M; Bassotti G
    Hum Pathol; 2008 Mar; 39(3):403-9. PubMed ID: 18261624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.
    Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P
    Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
    Montgomery E; Goldblum JR; Greenson JK; Haber MM; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Zahurak ML; Hart J
    Hum Pathol; 2001 Apr; 32(4):379-88. PubMed ID: 11331954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
    Abraham SC; Wang H; Wang KK; Wu TT
    Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study.
    van Olphen SH; Ten Kate FJC; Doukas M; Kastelein F; Steyerberg EW; Stoop HA; Spaander MC; Looijenga LHJ; Bruno MJ; Biermann K;
    Medicine (Baltimore); 2016 Nov; 95(47):e5402. PubMed ID: 27893678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus.
    Akgun H; Lechago J; Younes M
    Anticancer Res; 2002; 22(3):1459-61. PubMed ID: 12168823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus.
    van Dekken H; Hop WC; Tilanus HW; Haringsma J; van der Valk H; Wink JC; Vissers KJ
    Am J Clin Pathol; 2008 Nov; 130(5):745-53. PubMed ID: 18854267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
    Villanacci V; Rossi E; Zambelli C; Galletti A; Cestari R; Missale G; Casa DD; Bassotti G
    Dig Liver Dis; 2007 Apr; 39(4):305-11. PubMed ID: 17307036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasia.
    Younes M; Lechago J; Chakraborty S; Ostrowski M; Bridges M; Meriano F; Solcher D; Barroso A; Whitman D; Schwartz J; Johnson C; Schmulen AC; Verm R; Balsaver A; Carlson N; Ertant A
    Scand J Gastroenterol; 2000 Feb; 35(2):131-7. PubMed ID: 10720109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
    Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
    Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.